Business News

Nifty Pharma defies mkt slump, up 1% as select drugs exempt from US tariffs

FinSiddhi

Qualifying speciality medicines from India will be eligible for zero duty, providing some relief to Indian drugmakers with exposure to the US market.
Read more at the source

Disclaimer: The content of this post is sourced from external sites and is for informational purposes only. All rights and credits belong to the original authors and publishers.

Related Posts

SGX to drop India-linked single-stock futures

The Singapore Stock Exchange’s recent decision to halt trading in single stock futures linked to Indian equities marks a pivotal shift, likely spurred by Indian regulators’ scrutiny of derivative contract practices on SGX. This alteration may compel foreign investors to realign their approaches toward accessing Indian stocks, potentially resulting in increased trading activity at GIFT…

Woman quit her medical career in India and moved to the UK: What finally made her walk away

During her medical internship, an Indian intern became engulfed in severe burnout and persistent self-doubt. In pursuit of a healthier work atmosphere, she transitioned to the United Kingdom. There, a thought-provoking inquiry regarding her difficulties led to an ADHD and autism diagnosis, offering clarity on her enduring struggles. This story underscores the vital importance of…